Who Buys Immunoglobulin from India — 570 Importers Behind a $180.0M Market
India's immunoglobulin import market is served by 570 active buyers who collectively imported $180.0M across 1,841 shipments. STATE PHARMACEUTICALS CORPORATION (SRI LANKA) leads with a 8.6% market share, followed by AMBICA INTERNATIONAL CORPORATION and STATE PHARMACEUTICALS CORPORATION O. The top 5 buyers together control 27.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Immunoglobulin Importers — Ranked by Import Value
STATE PHARMACEUTICALS CORPORATION (SRI LANKA) is the leading immunoglobulin importer from India, holding a 8.6% share of the $180.0M market across 1,841 shipments from 570 buyers. The top 5 buyers — STATE PHARMACEUTICALS CORPORATION (SRI LANKA), AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), STATE PHARMACEUTICALS CORPORATION O (SRI LANKA), LIBRA CHILE S.A (CHILE), DROGUERIA MK LAB S.A.C (PERU) — collectively control 27.1% of total import value.
Top Immunoglobulin Buyers & Importers
Ranked by import value · 570 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | STATE PHARMACEUTICALS CORPORATIONSRI LANKA HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $15.5M | 5 | 8.6% |
| 2 | AMBICA INTERNATIONAL CORPORATIONPHILIPPINES GAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##(HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEGAMMA IV 5 GM [NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ] | $11.2M | 5 | 6.2% |
| 3 | STATE PHARMACEUTICALS CORPORATION OSRI LANKA HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $7.8M | 5 | 4.3% |
| 4 | LIBRA CHILE S.ACHILE HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $7.5M | 5 | 4.2% |
| 5 | DROGUERIA MK LAB S.A.CPERU HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $6.8M | 5 | 3.8% |
| 6 | PEACE WORLD GENERAL TRADING LLCUNITED ARAB EMIRATES GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $5.1M | 5 | 2.9% |
| 7 | NEXT PHARMA SOURCING SASCOLOMBIA HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $4.3M | 5 | 2.4% |
| 8 | SEGURO SOCIAL DEPERU HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $4.0M | 5 | 2.2% |
| 9 | LAZERHEAD CAPITAL LTDUNITED ARAB EMIRATES GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $3.6M | 5 | 2.0% |
| 10 | DROGUERIA MK LAB S A CPERU HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $3.3M | 5 | 1.8% |
| 11 | LAZERHEAD CAPITAL LIMITEDUNITED ARAB EMIRATES GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $3.2M | 5 | 1.8% |
| 12 | SEAN DOMINICAN SRLDOMINICAN REPUBLIC HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENTETGLOB 250.I.U [ TETANUS IMMUNOGLOBULIN B.P. ] | $3.2M | 5 | 1.8% |
| 13 | TRANSCEND DRUGSTOREISRAEL | $3.1M | 5 | 1.7% |
| 14 | SEGURO SOCIAL DE SALUD DELPERU HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $3.1M | 5 | 1.7% |
| 15 | SOLMEDICAGUATEMALA | $3.1M | 5 | 1.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Immunoglobulin — and from which countries?
Flow of Immunoglobulin exports from India: each country's share and the named importers behind the numbers
Immunoglobulin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Sri Lanka
Sri Lanka emerges as the first largest importing country, achieving a total trade value of $27.9M through 21 shipments. This represents a market share of 15.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• STATE PHARMACEUTICALS CORPORATION - $15.5M (55.5% of country's total business)
• STATE PHARMACEUTICALS CORPORATION O - $7.8M (28.0% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $1.3M, indicating premium pricing strategy compared to the market average of $97.8K.
Sri Lanka is a key market for Immunoglobulin imports, representing 15.5% of total trade value.
2United Arab Emirates
United Arab Emirates emerges as the second largest importing country, achieving a total trade value of $24.7M through 24 shipments. This represents a market share of 13.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Arab Emirates has a diverse importer base, with their top importers including:
• PEACE WORLD GENERAL TRADING LLC - $5.1M (20.8% of country's total business)
• LAZERHEAD CAPITAL LTD - $3.6M (14.5% of country's total business)
• LAZERHEAD CAPITAL LIMITED - $3.2M (13.1% of country's total business)
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $1.0M, indicating premium pricing strategy compared to the market average of $97.8K.
United Arab Emirates is a key market for Immunoglobulin imports, representing 13.7% of total trade value.
3Colombia
Colombia emerges as the third largest importing country, achieving a total trade value of $19.8M through 16 shipments. This represents a market share of 11.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Colombia has a diverse importer base, with their top importers including:
• NEXT PHARMA SOURCING SAS - $4.3M (21.9% of country's total business)
Key Insight: Colombia demonstrates strong market positioning with an average shipment value of $1.2M, indicating premium pricing strategy compared to the market average of $97.8K.
Colombia is a key market for Immunoglobulin imports, representing 11.0% of total trade value.
4Peru
Peru emerges as the fourth largest importing country, achieving a total trade value of $18.0M through 29 shipments. This represents a market share of 10.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Peru has a diverse importer base, with their top importers including:
• DROGUERIA MK LAB S.A.C - $6.8M (37.8% of country's total business)
• SEGURO SOCIAL DE - $4.0M (22.4% of country's total business)
• DROGUERIA MK LAB S A C - $3.3M (18.3% of country's total business)
• SEGURO SOCIAL DE SALUD DEL - $3.1M (17.0% of country's total business)
Key Insight: Peru demonstrates strong market positioning with an average shipment value of $619.4K, indicating premium pricing strategy compared to the market average of $97.8K.
Peru is a key market for Immunoglobulin imports, representing 10.0% of total trade value.
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $17.7M through 54 shipments. This represents a market share of 9.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• AMBICA INTERNATIONAL CORPORATION - $11.2M (63.6% of country's total business)
• BSV BIOSCIENCE PHILIPPINES INC. - $2.4M (13.7% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $327.0K, indicating premium pricing strategy compared to the market average of $97.8K.
Philippines is a key market for Immunoglobulin imports, representing 9.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Immunoglobulin buyer market intelligence
1Buyer Segment Analysis
The importation of Immunoglobulin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Government Procurement Agencies: Entities like the State Pharmaceuticals Corporation (Sri Lanka) and Seguro Social de Salud del (Peru) fall into this category. These agencies typically procure large volumes through national tenders to supply public healthcare facilities. Their purchasing is characterized by bulk orders, often aligned with government budgets and healthcare programs, ensuring consistent supply to meet public health demands.
Distributors: Companies such as Ambica International Corporation (Philippines) and Libra Chile S.A (Chile) act as intermediaries, sourcing Immunoglobulin to supply hospitals, clinics, and pharmacies. Their order patterns are influenced by market demand, and they often maintain inventory to ensure timely delivery to healthcare providers.
Re-exporters: Firms like Peace World General Trading LLC (United Arab Emirates) and Lazerhead Capital Ltd (United Arab Emirates) may import Immunoglobulin with the intent to re-export to neighboring regions. Their purchasing behavior is driven by regional demand fluctuations and opportunities in adjacent markets.
Hospital Groups and Retail Chains: While not explicitly listed among the top buyers, these entities typically procure Immunoglobulin directly from manufacturers or through distributors to meet the needs of their patients. Their order patterns are generally consistent, based on patient requirements and treatment protocols.
Contract Manufacturers: These are companies that produce Immunoglobulin on behalf of other firms. They may import raw materials or finished products to fulfill contractual obligations. Their purchasing is project-based and varies according to contractual agreements.
Understanding these segments is crucial for tailoring marketing strategies and ensuring efficient supply chain management in the Immunoglobulin market.
Country-Specific Import Regulations
TransData Nexus Immunoglobulin buyer market intelligence
1Country-Specific Import Regulations
Sri Lanka:
1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must obtain an import license from the NMRA, which involves submitting detailed product information, including quality standards and manufacturing practices.
3. Estimated Timeline for Registration: The registration process typically takes 3 to 6 months, depending on the completeness of the application and any required inspections.
4. Import Tariff/Duty for HS 30021290: Under the Indo-Sri Lanka Free Trade Agreement (ISFTA), certain pharmaceutical products may be exempt from customs duties. Importers should consult the latest tariff schedules to confirm applicable duties. (customs.gov.lk)
United Arab Emirates (UAE):
1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).
2. Import Registration Process: Importers are required to register pharmaceutical products with MOHAP, providing comprehensive documentation on product efficacy, safety, and quality.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, subject to the review process and any additional information requests.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in the UAE; however, importers should verify current regulations to ensure compliance.
Colombia:
1. Drug Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).
2. Import Registration Process: Importers must register pharmaceutical products with INVIMA, submitting detailed dossiers that include clinical data and manufacturing information.
3. Estimated Timeline for Registration: The registration process usually takes between 6 to 12 months, depending on the complexity of the product and the review process.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules for specific rates.
Peru:
1. Drug Regulatory Authority: General Directorate of Medicines, Supplies and Drugs (DIGEMID).
2. Import Registration Process: Importers are required to register pharmaceutical products with DIGEMID, providing comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the completeness of the application and any additional requirements.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in Peru; however, importers should verify current regulations to ensure compliance.
Philippines:
1. Drug Regulatory Authority: Food and Drug Administration (FDA) Philippines.
2. Import Registration Process: Importers must register pharmaceutical products with the FDA, submitting detailed dossiers that include clinical data, manufacturing information, and labeling.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the product's complexity and the review process.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules for specific rates.
Demand Drivers & Market Opportunity
TransData Nexus Immunoglobulin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Immunoglobulin in importing countries is driven by several key factors:
1. Disease Prevalence: Immunoglobulin is essential in treating primary immunodeficiency disorders and certain autoimmune diseases. The prevalence of these conditions necessitates a steady supply of Immunoglobulin to manage patient health effectively.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of including essential medicines in national procurement lists to ensure availability. (iris.who.int)
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Immunoglobulin, to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Inclusion of Immunoglobulin in the WHO Essential Medicines List encourages countries to prioritize its procurement, ensuring that patients have access to necessary treatments.
5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender-based procurement systems to acquire medicines. This approach can lead to competitive pricing and reliable supply chains for Immunoglobulin.
With 570 buyers across 119 countries, the global market for Immunoglobulin presents significant opportunities. Understanding the specific demand drivers in each region can aid suppliers in effectively meeting market needs and expanding their reach.
Common Questions — Immunoglobulin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest immunoglobulin buyer importing from India?
Based on import volume and value, STATE PHARMACEUTICALS CORPORATION (SRI LANKA) leads with $15.5M in imports and a 8.6% market share — the highest of any single immunoglobulin importer. AMBICA INTERNATIONAL CORPORATION (PHILIPPINES) and STATE PHARMACEUTICALS CORPORATION O (SRI LANKA) are the next largest buyers.
QHow many companies buy immunoglobulin from India?
There are 570 active immunoglobulin buyers importing from India, with a combined market of $180.0M across 1,841 shipments to 119 countries. The top 5 buyers hold 27.1% of total import value, while the remaining 565 buyers handle the other 72.9%.
QWhich countries import the most immunoglobulin from India?
The top importing countries for immunoglobulin from India are Sri Lanka (15.5%), United Arab Emirates (13.7%), Colombia (11.0%), Peru (10.0%), Philippines (9.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of immunoglobulin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for immunoglobulin from India?
The average import transaction value for immunoglobulin from India is $97.8K, with an average unit price of $86.09 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Immunoglobulin buyer market intelligence
1Buyer Segment Analysis
The importation of Immunoglobulin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Government Procurement Agencies: Entities like the State Pharmaceuticals Corporation (Sri Lanka) and Seguro Social de Salud del (Peru) fall into this category. These agencies typically procure large volumes through national tenders to supply public healthcare facilities. Their purchasing is characterized by bulk orders, often aligned with government budgets and healthcare programs, ensuring consistent supply to meet public health demands.
Distributors: Companies such as Ambica International Corporation (Philippines) and Libra Chile S.A (Chile) act as intermediaries, sourcing Immunoglobulin to supply hospitals, clinics, and pharmacies. Their order patterns are influenced by market demand, and they often maintain inventory to ensure timely delivery to healthcare providers.
Re-exporters: Firms like Peace World General Trading LLC (United Arab Emirates) and Lazerhead Capital Ltd (United Arab Emirates) may import Immunoglobulin with the intent to re-export to neighboring regions. Their purchasing behavior is driven by regional demand fluctuations and opportunities in adjacent markets.
Hospital Groups and Retail Chains: While not explicitly listed among the top buyers, these entities typically procure Immunoglobulin directly from manufacturers or through distributors to meet the needs of their patients. Their order patterns are generally consistent, based on patient requirements and treatment protocols.
Contract Manufacturers: These are companies that produce Immunoglobulin on behalf of other firms. They may import raw materials or finished products to fulfill contractual obligations. Their purchasing is project-based and varies according to contractual agreements.
Understanding these segments is crucial for tailoring marketing strategies and ensuring efficient supply chain management in the Immunoglobulin market.
Country-Specific Import Regulations
TransData Nexus Immunoglobulin buyer market intelligence
1Country-Specific Import Regulations
Sri Lanka:
1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must obtain an import license from the NMRA, which involves submitting detailed product information, including quality standards and manufacturing practices.
3. Estimated Timeline for Registration: The registration process typically takes 3 to 6 months, depending on the completeness of the application and any required inspections.
4. Import Tariff/Duty for HS 30021290: Under the Indo-Sri Lanka Free Trade Agreement (ISFTA), certain pharmaceutical products may be exempt from customs duties. Importers should consult the latest tariff schedules to confirm applicable duties. (customs.gov.lk)
United Arab Emirates (UAE):
1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).
2. Import Registration Process: Importers are required to register pharmaceutical products with MOHAP, providing comprehensive documentation on product efficacy, safety, and quality.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, subject to the review process and any additional information requests.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in the UAE; however, importers should verify current regulations to ensure compliance.
Colombia:
1. Drug Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).
2. Import Registration Process: Importers must register pharmaceutical products with INVIMA, submitting detailed dossiers that include clinical data and manufacturing information.
3. Estimated Timeline for Registration: The registration process usually takes between 6 to 12 months, depending on the complexity of the product and the review process.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules for specific rates.
Peru:
1. Drug Regulatory Authority: General Directorate of Medicines, Supplies and Drugs (DIGEMID).
2. Import Registration Process: Importers are required to register pharmaceutical products with DIGEMID, providing comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the completeness of the application and any additional requirements.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in Peru; however, importers should verify current regulations to ensure compliance.
Philippines:
1. Drug Regulatory Authority: Food and Drug Administration (FDA) Philippines.
2. Import Registration Process: Importers must register pharmaceutical products with the FDA, submitting detailed dossiers that include clinical data, manufacturing information, and labeling.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the product's complexity and the review process.
4. Import Tariff/Duty for HS 30021290: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules for specific rates.
Demand Drivers & Market Opportunity
TransData Nexus Immunoglobulin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Immunoglobulin in importing countries is driven by several key factors:
1. Disease Prevalence: Immunoglobulin is essential in treating primary immunodeficiency disorders and certain autoimmune diseases. The prevalence of these conditions necessitates a steady supply of Immunoglobulin to manage patient health effectively.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of including essential medicines in national procurement lists to ensure availability. (iris.who.int)
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Immunoglobulin, to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Inclusion of Immunoglobulin in the WHO Essential Medicines List encourages countries to prioritize its procurement, ensuring that patients have access to necessary treatments.
5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender-based procurement systems to acquire medicines. This approach can lead to competitive pricing and reliable supply chains for Immunoglobulin.
With 570 buyers across 119 countries, the global market for Immunoglobulin presents significant opportunities. Understanding the specific demand drivers in each region can aid suppliers in effectively meeting market needs and expanding their reach.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 570 global importers of Immunoglobulin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,841 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 119 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,841 Verified Shipments
570 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists